(Q36376255)

13 August 2017

Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease (English)

1 reference

13 August 2017

0 references

Hye Won Lee

5

0 references

Jae Hee Cheon

object named as

Jae Hee Cheon

12

0 references

0 references

8

Sung Pil Hong

1 reference

13 August 2017

Hyun Jung Lee

1

1 reference

13 August 2017

Jae Hyun Kim

2

1 reference

13 August 2017

Seung Won Kim

3

1 reference

13 August 2017

Hyun Ah Joo

4

1 reference

13 August 2017

You Sun Kim

6

1 reference

13 August 2017

Soo Jung Park

7

1 reference

13 August 2017

Tae Il Kim

9

1 reference

13 August 2017

Won Ho Kim

10

1 reference

13 August 2017

Young-Ho Kim

11

1 reference

13 August 2017

18 May 2017

1 reference

Digestive Diseases and Sciences

13 August 2017

1 reference

13 August 2017

62

1 reference

13 August 2017

8

1 reference

13 August 2017

1953-1962

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-017-4606-y

13 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Commensal flora: wolf in sheep's clothing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Gastrointestinal manifestations of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Gastrointestinal manifestations of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

New proteomic approaches for biomarker discovery in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Current advantages in the application of proteomics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Current application of proteomics in biomarker discovery for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Single-step perfusion chromatography with a throughput potential for enhanced peptide detection by matrix-assisted laser desorption/ ionization-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Serum amyloid A in autoimmune thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Biomarkers of Inflammation in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Proteomics to study genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Blood-based proteomics for personalized medicine: examples from neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Utilizing human blood plasma for proteomic biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Apolipoprotein A-IV inhibits experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Plasticity and cross-talk of interleukin 6-type cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Serum amyloid A, the major vertebrate acute-phase reactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Is serum amyloid A an endogenous TLR4 agonist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4606-Y

Extrahepatic production of acute phase serum amyloid A.

21 January 2018

1 reference

12 December 2020

Apolipoprotein A-IV Is an Independent Predictor of Disease Activity in Patients with Inflammatory Bowel Disease

1 reference

12 December 2020

IL-6 signal transduction and its physiological roles: the signal orchestration model

1 reference

12 December 2020

Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease

1 reference

12 December 2020

Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease

1 reference

12 December 2020

Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease

1 reference

12 December 2020

Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach

1 reference

12 December 2020

10.1007/S10620-017-4606-Y

Identifiers

DOI

1 reference

13 August 2017

1 reference